Recent advances in bionanomaterials for liver cancer diagnosis and treatment

Mohammed Mehadi Hassan Chowdhury1, Christiancel Joseph J Salazar2, Md Nurunnabi3

  • 1School of Medicine, Faculty of Health, Deakin University, 75 Pigdons Road, Waurnponds, Vic-3216, Australia and Department of Microbiology, Noakhali Science and Technology University, Noakhali-3814, Bangladesh.

Insights

Nanotechnology offers promising solutions for liver cancer, enhancing early diagnosis and treatment. Nanoparticles show potential to overcome current limitations in managing this deadly disease.

Area of Science:

  • Oncology
  • Nanotechnology
  • Biomedical Engineering

Background:

  • Liver cancer is a major global health concern, ranking as the fourth leading cause of cancer death worldwide.
  • Current treatment and diagnostic strategies face challenges including recurrence, metastasis, and late diagnosis.

Purpose of the Study:

  • To review key advances in nanoparticle applications for liver cancer diagnosis and treatment.
  • To explore the potential of nanotechnology in overcoming existing therapeutic limitations for liver cancer.

Main Methods:

  • Review of recent scientific literature on nanoparticle-based diagnostic and therapeutic modalities for liver cancer.
  • Analysis of clinical trial progress and future potential of nanotechnology in oncology.

Main Results:

  • Nanoparticle-based approaches are advancing rapidly, with several entering clinical trials.
  • Nanotechnology demonstrates significant promise for improving early detection and targeted treatment of liver cancer.

Conclusions:

  • Nanoparticles represent a promising frontier in liver cancer management.
  • Further development in nanoparticle-mediated strategies could revolutionize clinical outcomes for liver cancer patients.